Internal Medicine

Clinical trials for Internal Medicine specialty

  • Description

    To evaluate the effect of plavix dosing in respect to how much time is needed to achieve maximum platelet inhibition which may decrease risk of thrombeombolic disease.

    Inclusion Criteria

    Diagnosis of protein losing nephropathy, cases with high indices of suspicion without definitive diagnosis will also be considered.

    Exclusion Criteria

    Dogs will be excluded if they have received steroids or any anticoagulant medications.

    Client Benefits

    May be able to use a lower dose of plavix, therefore, more cost-effective.

    Contact Information

    Dr. Melissa Bucknoff, DVM
    Phonoe: (508) 839-5395

  • Description

    To investigate and identify occult coagulation disorders in cats with cholestatic liver disease before any procedures (FNA, biopsy, surgery, e-tube placement).

    Inclusion Criteria

    serum bilirubin >/= 3, ALT/ALP > 2x upper limit of reference range.

    Exclusion Criteria

    PCV < 28%, obvious neoplasia, heart disease, icterus due to sepsis or hemolysis, meds (NSAIDs, steroids, fatty acids).

    Client Benefits

    PT/PTT, plt count, pcv/ts, and TEG

    Contact Information

    Gideon.Daniel@tufts.edu